Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $7.0000 (-0.71%) ($6.9000 - $7.2500) on Mon. Jun. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.77% (three month average) | RSI | 22 | Latest Price | $7.0000(-0.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -0.6% a day on average for past five trading days. | Weekly Trend | ANPC declines -3.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLB(11%) PCY(10%) LIT(9%) HYG(8%) IPO(8%) | Factors Impacting ANPC price | ANPC will decline at least -1.885% in a week (0% probabilities). SHY(-17%) XBI(-7%) IBB(-7%) XLU(-6%) IGOV(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.885% (StdDev 3.77%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
1 - 5 Day Possible Target | $0(-100%) | Resistance Level | $7.48 | 5 Day Moving Average | $7.09(-1.27%) | 10 Day Moving Average | $7.26(-3.58%) | 20 Day Moving Average | $7.48(-6.42%) | To recent high | -17.6% | To recent low | 1.2% | Market Cap | $60m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |